Any promotional activity, including so-called awareness campaigns, that functions as a surrogate advertisement for prescription-only drugs shall be viewed seriously and may be treated as irrational or misleading marketing practice, stated Dr Rajeev Singh Raghuvanshi, Drugs Controller General of India
Why GLP-1 patches is misleading The name GLP-1 patches suggests these products contain or deliver GLP-1 hormones, but this is fundamentally incorrect
Mild allodynia: You notice increased skin sensitivity, but it does not significantly interfere with daily activities
Diabetic polyneuropathy (DPN) is the most common late complication of diabetes mellitus
In upcoming articles, we will explore dosing strategies, safety considerations, and comparisons with other treatment options to support more informed clinical and patient decisions.
Thiazolidinediones Thiazolidinediones (TZDs), (also called glitazones) were introduced in 1996 for T2DM, when troglitazone (Rezulin